Skip to main content
GMAB logo

GMAB

Genmab A/S
$28.73 -0.07 (-0.24%) At close · Jul 14
Market Cap
$17.87B
Shares
613,935,890

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Past events

Date Event Type
2026-05-07 Publication of the Interim Report for the First Quarter 2026 (after 5:00 PM CEST) Event
2026-03-19 Annual General Meeting 2026 Event
2026-03-11 Barclays 28th Annual Global Healthcare Conference Conference
2026-03-10 Leerink Global Healthcare Conference Conference
2026-03-03 TD Cowen 46th Annual Healthcare Conference Conference
2026-02-17 Publication of the Annual Report for 2025 (after 5:00 PM CET) Event
2026-01-13 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-31 Financial Calendar Year End Event
2025-12-11 2025 R&D Update and ASH Data Review Event
2025-12-04 Citi 2025 Global Healthcare Conference Conference
2025-11-19 Jefferies Healthcare Conference Conference
2025-11-06 Publication of the Interim Report for the First Nine Months 2025 (after 5:00 PM CET) Event
2025-09-29 Genmab's Proposed Acquisition of Merus Event
2025-09-23 Bank of America 2025 Global Healthcare Conference Conference
2025-09-09 Morgan Stanley 23rd Annual Global Healthcare Conference Conference
2025-08-07 Publication of the Interim Report for the First Half 2025 (after 5:00 PM CEST) Event
2025-06-09 Goldman Sachs 46th Annual Global Healthcare Conference Conference
2025-06-05 2025 Jefferies Global Healthcare Conference Conference
2025-06-02 Post-ASCO R&D Update Event
2025-05-08 Publication of the Interim Report for the First Quarter 2025 (after 5:00 PM CEST) Event
2025-03-12 Annual General Meeting 2025 Event
2025-03-10 Genmab's Investor Call Regarding HexaBody-CD38 Event
2025-03-03 TD Cowen 45th Annual Health Care Conference Conference
2025-02-12 Publication of the Annual Report for 2024 (after 5:00 PM CET) Event
2025-01-28 Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors Shareholder meeting

Source: https://ir.genmab.com/

Key facts CIK 1434265 CUSIP 372303206 13F (30d) 22 filings 21 filers Visit website Investor relations